Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapaconazole vs Ketoconazole in Tinea Pedis
NCT03320486Phase 3Completed
- Sponsor
- Biolab Farmacêutica
- Start
- Nov 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapaconazole in tinea pedis, sponsored by Biolab Farmacêutica. Started Nov 2017; status: completed.
02
Drugs
dapaconazole
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT03320486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320486.